Ahh gotcha, thanks for the correction.
still id expect the difference between groups should be bigger considering legacy effect can only affect 1/2 the patients at most and you wouldn’t expect a legacy effect in the low albuminuria subgroup considering they didn’t get drug efficacy there
anyway just my opinion, but I could be wrong!
Ann: Positive Top-Line Results in DKD Phase 2 Clinical Study, page-335
-
- There are more pages in this discussion • 293 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
39.0¢ |
Change
-0.010(2.50%) |
Mkt cap ! $217.3M | |||
| Open | High | Low | Value | Volume |
| 40.0¢ | 40.5¢ | 39.0¢ | $370.0K | 934.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 25531 | 39.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.0¢ | 7985 | 1 |
View Market Depth
| Last trade - 16.10pm 01/11/2024 (20 minute delay) ? |
| DXB (ASX) Chart |